Efficacy and Safety of DTG/3TC in Treatment-naïve HIV-1 Infected Patients

Enrolling by invitationOBSERVATIONAL

Enrollment

200

Participants

Timeline

Start Date

January 24, 2025

Primary Completion Date

December 30, 2025

Study Completion Date

January 30, 2027

Conditions

HIV

Interventions

DRUG

DTG + 3TC FDC

None(Non-interventional, retrospective chart review, single-arm study )

Trial Locations (1)

Chungnam National University Hospital, 282 Munwha-ro, Daejeon

All Listed Sponsors

lead

Chungnam National University Hospital

OTHER